222 related articles for article (PubMed ID: 26614745)
1. IL-10-producing regulatory B cells are decreased in patients with psoriasis.
Hayashi M; Yanaba K; Umezawa Y; Yoshihara Y; Kikuchi S; Ishiuji Y; Saeki H; Nakagawa H
J Dermatol Sci; 2016 Feb; 81(2):93-100. PubMed ID: 26614745
[TBL] [Abstract][Full Text] [Related]
2. Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid.
Kabuto M; Fujimoto N; Takahashi T; Tanaka T
Br J Dermatol; 2017 May; 176(5):1204-1212. PubMed ID: 27716906
[TBL] [Abstract][Full Text] [Related]
3. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
[TBL] [Abstract][Full Text] [Related]
4. CD70-mediated CD27 expression downregulation contributed to the regulatory B10 cell impairment in rheumatoid arthritis.
Shi L; Hu F; Zhu L; Xu C; Zhu H; Li Y; Liu H; Li C; Liu N; Xu L; Mu R; Li Z
Mol Immunol; 2020 Mar; 119():92-100. PubMed ID: 32006824
[TBL] [Abstract][Full Text] [Related]
5. Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.
Akatsuka T; Miyagaki T; Nakajima R; Kamijo H; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Jun; 28(3):314-319. PubMed ID: 29952298
[TBL] [Abstract][Full Text] [Related]
6. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
[TBL] [Abstract][Full Text] [Related]
7. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
8. Decrease in the proportion of CD24
Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
[TBL] [Abstract][Full Text] [Related]
9. Purification and Immunophenotypic Characterization of Human CD19
Bradford HF; Mauri C
Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
[TBL] [Abstract][Full Text] [Related]
10. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of regulatory B10 cells in patients with rheumatoid arthritis with different disease status.
Zheng Z; Li X; Li X; Ding J; Feng Y; Miao J; Luo X; Wu Z; Zhu P
Mol Med Rep; 2015 Sep; 12(3):4584-4591. PubMed ID: 26081876
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CD19
Gu Y; Li K; Sun J; Zhang J
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
Front Immunol; 2021; 12():713351. PubMed ID: 34566969
[TBL] [Abstract][Full Text] [Related]
15. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
[TBL] [Abstract][Full Text] [Related]
16. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation.
Yanaba K; Kamata M; Ishiura N; Shibata S; Asano Y; Tada Y; Sugaya M; Kadono T; Tedder TF; Sato S
J Leukoc Biol; 2013 Oct; 94(4):563-73. PubMed ID: 23630391
[TBL] [Abstract][Full Text] [Related]
17. IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells.
Mavropoulos A; Varna A; Zafiriou E; Liaskos C; Alexiou I; Roussaki-Schulze A; Vlychou M; Katsiari C; Bogdanos DP; Sakkas LI
Clin Immunol; 2017 Nov; 184():33-41. PubMed ID: 28461105
[TBL] [Abstract][Full Text] [Related]
18. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
19. Frequency of CD19
Zhao Q; Jung LK
Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
[TBL] [Abstract][Full Text] [Related]
20. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
